The Big Business Behind Weight Loss Drugs

Thinning hair, shedding, and sudden graying can send people searching for answers. This week, Sanjay speaks with dermatologist and Harvard assistant professor Dr. Maryanne Makredes Senna about what could be driving hair loss, what to watch for, and which treatments are actually w ...  Show more

After a deadly outbreak on an expedition cruise ship, listeners have questions about hantavirus and what it means for them. Sanjay breaks down what we know about how it spreads, and how worried you actually need to be. Plus, what experts are saying about the pandemic potential of ...  Show more

WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: why is a company built on personal accountability facilitating medical interventi ...  Show more

A discussion of claims that obesity is mostly due to genetics. (1:30) Should a pharmaceutical company be for profit? (7:38) What is Big Pharma's motivation behind these claims? (10:09) What does obesity contribute to? (15:52) Is capitalism to blame? (21:14) Lifestyle is EVERYTHIN ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

In this episode, Abby and Jillian discuss the increased popularity of GLP-1 agonist medications like Ozempic & Wegovy for weight loss. Their focus with this conversation is not to argue for or against the use of these medications. Their goal is to help you better understand what ...  Show more